Literature DB >> 9806904

Recombinant human glutathione S-transferases catalyse enzymic isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro.

H Chen1, M R Juchau.   

Abstract

The steric conversion of 13-cis-retinoic acid (13-cRA) to all-trans-retinoic acid (t-RA) has been proposed as an activation mechanism for the observed therapeutic and teratogenic activities of 13-cRA. Here we have investigated the catalysis of isomerization of 13-cRA to t-RA by recombinant human glutathione S-transferases (GSTs). Substrate was incubated with GST in 0.1 M sodium phosphate buffer, pH 7.5, at 37 degrees C in total darkness. The t-RA generated was measured quantitatively by HPLC. Under the reaction conditions used, GSTP1-1 was far more effective than human GSTM1-1 or human GSTA1-1 in catalysing the isomerization reaction. The reaction catalysed by GSTP1-1 showed substrate saturation and the Km and Vmax values for the reaction were approx. 7 microM and 650 pmol/min per nmol respectively. The reaction rate increased linearly with increasing enzyme concentration. The reaction was inhibited both by heat treatment and by S-decylglutathione (a potent inhibitor of transferase activity associated with GST). Additions of polyclonal rabbit antiserum for human GSTP1-1 to the reaction resulted in a significant decrease in generation of t-RA (70-80%). In addition, ethacrynic acid, a selective substrate for Pi isoforms of GST, also inhibited the isomerization of 13-cRA to t-RA catalysed by GSTP1-1. Under the same reaction conditions, GSTP1-1 was much less effective in catalysing the steric conversion of 9-cis-retinoic acid to t-RA, indicating that the enzyme was stereospecific for the conversion of 13-cRA to t-RA. These observations suggest that enzymic catalysis was the primary mechanism for the GSTP1-1-dependent conversion of 13-cRA to t-RA. Reactions catalysed by a purified rat hepatic GST Pi isoenzyme proceeded more slowly than reactions catalysed by human GSTP1-1. Comparative studies also showed that there were marked species differences in catalytic activities between various purified mammalian hepatic GST mixtures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806904      PMCID: PMC1219861          DOI: 10.1042/bj3360223

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Glutathione S-transferases act as isomerases in isomerization of 13-cis-retinoic acid to all-trans-retinoic acid in vitro.

Authors:  H Chen; M R Juchau
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Nonenzymatic isomerization of 9-cis-retinoic acid catalyzed by sulfhydryl compounds.

Authors:  T W Shih; T H Lin; Y F Shealy; D L Hill
Journal:  Drug Metab Dispos       Date:  1997-01       Impact factor: 3.922

Review 4.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

Authors:  J D Hayes; D J Pulford
Journal:  Crit Rev Biochem Mol Biol       Date:  1995       Impact factor: 8.250

5.  Retinol forms retinoic acid via retinal.

Authors:  C I Kim; M A Leo; C S Lieber
Journal:  Arch Biochem Biophys       Date:  1992-05-01       Impact factor: 4.013

6.  Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid.

Authors:  J Urbach; R R Rando
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

7.  Thiol dependent isomerization of all-trans-retinoic acid to 9-cis-retinoic acid.

Authors:  J Urbach; R R Rando
Journal:  FEBS Lett       Date:  1994-09-12       Impact factor: 4.124

8.  Glutathione transferases. Catalysis of nucleophilic reactions of glutathione.

Authors:  J H Keen; W B Jakoby
Journal:  J Biol Chem       Date:  1978-08-25       Impact factor: 5.157

9.  Enzymatic transformation of PGH2 to PGF2 alpha catalyzed by glutathione S-transferases.

Authors:  J R Burgess; H Yang; M Chang; M K Rao; C P Tu; C C Reddy
Journal:  Biochem Biophys Res Commun       Date:  1987-01-30       Impact factor: 3.575

10.  Nonenzymatic isomerization of all-trans- and 13-cis-retinoids catalyzed by sulfhydryl groups.

Authors:  T W Shih; Y F Shealy; D L Strother; D L Hill
Journal:  Drug Metab Dispos       Date:  1986 Nov-Dec       Impact factor: 3.922

View more
  6 in total

1.  Characterization and cloning of avian-hepatic glutathione S-transferases.

Authors:  C H Hsieh; L F Liu; S P Tsai; M F Tam
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 2.  Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily.

Authors:  D Sheehan; G Meade; V M Foley; C A Dowd
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

Review 3.  The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.

Authors:  Takahiko Kogai; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

4.  The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease.

Authors:  C J Carter
Journal:  ISRN Neurol       Date:  2011-07-12

5.  Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer.

Authors:  Shuo Wei; Shingo Kozono; Lev Kats; Morris Nechama; Wenzong Li; Jlenia Guarnerio; Manli Luo; Mi-Hyeon You; Yandan Yao; Asami Kondo; Hai Hu; Gunes Bozkurt; Nathan J Moerke; Shugeng Cao; Markus Reschke; Chun-Hau Chen; Eduardo M Rego; Francesco Lo-Coco; Lewis C Cantley; Tae Ho Lee; Hao Wu; Yan Zhang; Pier Paolo Pandolfi; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Med       Date:  2015-04-13       Impact factor: 53.440

6.  Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor.

Authors:  Jacky K Leung; Yusuke Imamura; Minoru Kato; Jun Wang; Nasrin R Mawji; Marianne D Sadar
Journal:  Commun Biol       Date:  2021-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.